Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $159,519 | $137,545 | $91,386 | $63,301 |
| Dep. & Amort. | $57,205 | $41,777 | $28,741 | $26,752 |
| Deferred Tax | -$17,872 | -$13,737 | -$15,751 | $4,209 |
| Stock-Based Comp. | $24,368 | $20,242 | $17,860 | $18,687 |
| Change in WC | -$14,547 | -$24,209 | -$32,177 | -$1,924 |
| Other Non-Cash | $4,713 | $21,885 | -$878 | -$13,031 |
| Operating Cash Flow | $213,386 | $183,503 | $89,181 | $97,994 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$41,041 | -$38,166 | -$24,034 | -$27,456 |
| Net Acquisitions | -$129,000 | -$506,406 | $421 | $0 |
| Inv. Purchases | -$76,792 | -$144,556 | -$35,761 | -$17,375 |
| Inv. Sales/Matur. | $126,022 | $38,622 | $27,969 | $18,771 |
| Other Inv. Act. | -$4,119 | $1,390 | -$1,372 | -$2,612 |
| Investing Cash Flow | -$124,930 | -$649,116 | -$32,777 | -$28,672 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10,170 | $526,342 | -$1,781 | $32,099 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$85,458 | -$58,144 | -$39,909 | -$28,873 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,665 | -$14,105 | $15,251 | -$40,244 |
| Financing Cash Flow | -$80,953 | $454,093 | -$26,439 | -$37,018 |
| Forex Effect | -$190 | -$282 | -$220 | -$223 |
| Net Chg. in Cash | $7,313 | -$11,802 | $29,745 | $32,081 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $144,531 | $156,333 | $126,588 | $94,507 |
| End Cash | $151,844 | $144,531 | $156,333 | $126,588 |
| Free Cash Flow | $172,345 | $145,337 | $65,147 | $70,538 |